Page last updated: 2024-08-23

androstane-3,17-diol and Hormone-Dependent Neoplasms

androstane-3,17-diol has been researched along with Hormone-Dependent Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamski, J; Breitling, R; Krazeisen, A; Möller, G1

Other Studies

1 other study(ies) available for androstane-3,17-diol and Hormone-Dependent Neoplasms

ArticleYear
Human 17beta-hydroxysteroid dehydrogenase type 5 is inhibited by dietary flavonoids.
    Advances in experimental medicine and biology, 2002, Volume: 505

    Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Androstane-3,17-diol; Androstenedione; Androsterone; Anticarcinogenic Agents; Binding Sites; Diet; Enzyme Inhibitors; Estrogens, Non-Steroidal; Flavonoids; Humans; Hydroxylation; Hydroxyprostaglandin Dehydrogenases; Isoflavones; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Phytoestrogens; Plant Preparations; Plants, Edible; Recombinant Fusion Proteins; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Testosterone

2002